Clinical trials in St. Poelten – page 3

The cardiovascular diseases research activity in St. Pölten focuses on improving outcomes for people with high-risk heart and vascular conditions. Trials are examining whether new approaches can better reduce major cardiovascular events and ease the burden of complex heart disease.

• Atherosclerotic cardiovascular disease
• Elevated lipoprotein(a)
• Hypertrophic cardiomyopathy

These studies aim to test treatment effectiveness and lower the risk of serious complications in patients with difficult-to-manage cardiovascular conditions.

Research in eye diseases is centered on neovascular age-related macular degeneration, with an emphasis on making care more practical in everyday clinical settings. The work reflects a strong interest in improving how patients are monitored and treated.

• Neovascular AMD
• Real-world treatment assessment

In St. Pölten, this area of research is helping evaluate ways to support better eye care while reducing treatment burden for patients and clinics.

Immune system diseases are represented by trials in allergic rhinoconjunctivitis and chronic hepatitis D infection. These studies are exploring new options to manage immune-related conditions and improve symptom control.

• Birch pollen-induced allergic rhinoconjunctivitis
• Chronic hepatitis D infection

The research is designed to assess whether emerging therapies can offer better relief or disease control for patients living with persistent immune-driven illnesses.

Neoplasm research in St. Pölten spans both solid tumors and advanced cancer care, including studies in melanoma, hepatocellular carcinoma, and metastatic pancreatic ductal adenocarcinoma. The goal is to improve treatment effectiveness and survival in cancers that can be hard to treat.

• Melanoma
• Intermediate-stage hepatocellular carcinoma
• Metastatic pancreatic ductal adenocarcinoma

These trials are testing new cancer treatment strategies and comparing them with established care to find better options for patients.

Work in virus diseases is addressing chronic hepatitis D, a serious viral infection that can lead to long-term liver damage. The studies are focused on finding more effective ways to control the disease.

• Chronic hepatitis D infection

This area of research is aimed at evaluating new therapies against current treatment options and improving care for patients with persistent viral illness.

Clinical trials in psychiatry and psychology are centered on mild to moderate major depressive disorder. The research is looking at whether new treatment options can better reduce depressive symptoms and support recovery.

• Mild to moderate major depressive disorder

These studies are intended to clarify treatment benefit and help identify therapies that may offer meaningful relief for people living with depression.